Robert W. Baird Raises Oscar Health (NYSE:OSCR) Price Target to $33.00

Key Points

• Robert W. Baird raised Oscar Health’s price target to $33 from $27 while maintaining a “neutral” rating, implying roughly 2.34% upside from the reported $32.24 share price.
• Analyst sentiment remains mixed, with Oscar Health carrying a consensus “Hold” rating and an average price target of $28.20. Recent targets range from $26 to $36.
• Oscar Health reported strong quarterly results, including $1.10 adjusted EPS versus a $0.40 estimate and $4.88 billion in revenue, up 70.4% year over year; insiders have nonetheless sold more than $126.8 million of stock over the past 90 days.

Oscar Health (NYSE:OSCR - Get Free Report) had its price target upped by analysts at Robert W. Baird from $27.00 to $33.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a "neutral" rating on the stock. Robert W. Baird's price objective would indicate a potential upside of 2.34% from the stock's current price.

A number of other brokerages also recently issued reports on OSCR. Wall Street Zen upgraded Oscar Health from a "buy" rating to a "strong-buy" rating in a report on Sunday, June 14th. Piper Sandler reaffirmed an "overweight" rating and issued a $36.00 price target on shares of Oscar Health in a report on Tuesday, July 28th. The Goldman Sachs Group reaffirmed a "neutral" rating and set a $30.00 target price on shares of Oscar Health in a report on Tuesday, August 11th. UBS Group boosted their target price on shares of Oscar Health from $20.00 to $26.00 and gave the company a "neutral" rating in a research report on Friday, August 7th. Finally, Bank of America restated an "underperform" rating and issued a $30.00 price objective on shares of Oscar Health in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Oscar Health presently has an average rating of "Hold" and a consensus target price of $28.20.

Oscar Health Stock Performance

Shares of NYSE:OSCR opened at $32.24 on Thursday. The firm's 50 day simple moving average is $30.70 and its 200-day simple moving average is $23.83. The firm has a market cap of $9.95 billion, a PE ratio of 23.03, a price-to-earnings-growth ratio of 0.48 and a beta of 2.37. Oscar Health has a one year low of $10.69 and a one year high of $34.48. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.Oscar Health's revenue was up 70.4% on a year-over-year basis. During the same period in the previous year, the company posted ($0.89) EPS. As a group, equities analysts predict that Oscar Health will post 1.54 EPS for the current year.

Insider Activity at Oscar Health

In related news, insider Janet Liang sold 10,360 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $325,822.00. Following the completion of the sale, the insider owned 248,697 shares of the company's stock, valued at approximately $7,821,520.65. This trade represents a 4.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Victoria Baltrus sold 958 shares of Oscar Health stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $30,129.10. Following the transaction, the chief accounting officer owned 213,631 shares in the company, valued at approximately $6,718,694.95. This represents a 0.45% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 4,322,257 shares of company stock worth $126,818,346 over the last 90 days. Corporate insiders own 22.64% of the company's stock.

Hedge Funds Weigh In On Oscar Health

Several large investors have recently made changes to their positions in OSCR. CoreCap Advisors LLC raised its holdings in shares of Oscar Health by 526.3% in the 2nd quarter. CoreCap Advisors LLC now owns 1,190 shares of the company's stock valued at $34,000 after buying an additional 1,000 shares during the period. GAMMA Investing LLC raised its stake in Oscar Health by 32.9% in the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company's stock valued at $41,000 after buying an additional 357 shares in the last quarter. FNY Investment Advisers LLC purchased a new stake in shares of Oscar Health during the 2nd quarter worth approximately $57,000. Allworth Financial LP lifted its holdings in shares of Oscar Health by 124.9% in the 2nd quarter. Allworth Financial LP now owns 2,031 shares of the company's stock valued at $58,000 after purchasing an additional 1,128 shares during the last quarter. Finally, IFP Advisors Inc boosted its stake in Oscar Health by 69.5% during the 2nd quarter. IFP Advisors Inc now owns 2,139 shares of the company's stock worth $61,000 after purchasing an additional 877 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company's primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.